medical devices
-
MedCity Influencers, Devices & Diagnostics
Weathering the good and the bad: Why good business practices work
For most companies and medtech, in particular, good business practices (GBP) happens on multiple levels. On the micro level, it’s more prescriptive (i.e., regulatory best practices or good manufacturing practices). On the macro level, it’s expressed as a set of ethics and principles that govern a company’s conduct.
-
Carrot Health founder launches SPV-only health tech VC fund
Engage Venture Partners, a Minneapolis-based venture capital firm, recently launched with a focus on early stage medical tech companies. The firm was established to decrease friction between early stage medical tech companies and their investors by bringing its investments to market via special purpose vehicles (SPVs).
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Convergence of medtech and health tech: Helping providers plan procedures and easing patient anxiety
A pediatric health system enlisting mixed reality and 3D printing technology illustrates how clinical collaboration and patient education can improve patient outcomes for complex procedures.
-
MedShift CEO shares vision for growth
A veteran of GE Healthcare, Joe Gasque talks about how he's growing the company's niche position in the high-paced aesthetics industry, offering services to surgeons, practitioners, medical device and injectables manufacturers.
-
Skeptical of future performance, spooked by recent misses, Needham analyst downgrades Medtronic’s stock
Mike Matson evaluated two earlier negative bits of information along with Thursday’s revenue and earnings-per-share miss to conclude that Medtronic’s stock, which has held up despite recent market swings, needs to be downgraded to a “hold” from a “buy”.
-
Using AI to reduce false alerts for patients with heart monitoring devices to detect cardiac arrhythmias
An infographic illustrates how Medtronic’s AccuRhythm AI suppresses false alerts while maintaining sensitivity.
-
With the FTC’s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC’s concerns.
-
Artificial Intelligence, BioPharma
Biofourmis adds $300M to ramp up in virtual care, digital therapy clinical trials
The Series D round of funding makes Biofourmis a unicorn valued at $1.3 billion. CEO and founder Kuldeep Singh Rajput said that the new capital will be used to expand his company’s remote-monitoring technologies and continue development of digital therapeutics, both as companions to traditional drugs and as monotherapies.
-
3D printers have proved their value to hospitals for limb-saving surgery, Covid-19 supply chain issues, and more
A recent webinar sponsored by Formlabs underscored the value of 3D printing from a clinical perspective and offered insight on how commercial and regulatory players are thinking about this space.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
Devices & Diagnostics, BioPharma
Becton Dickinson spins off diabetes biz, enabling Embecta to embark on its own
The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.
-
Devices & Diagnostics, Sponsored Post
3D Printed medical devices for precision surgery
Formlabs is sponsoring a webinar exploring 3D printing from clinical, commercial, and regulatory perspectives.
-
Devices & Diagnostics, BioPharma
Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three
Bausch + Lomb is returning to the public markets in an IPO expected to rank among the biggest in healthcare. Speaking at the annual J.P. Morgan Healthcare Conference, Bausch Health Companies CEO Joe Papa discussed the plans to spin off both the iconic eye products business as well as the skin products business, leaving three independent and publicly traded companies.
-
Health Tech, Sponsored Post, SYN
The new season of surgery evolution
We are building upon the foundation of digital laparoscopy and adding machine vision, augmented intelligence, and deep learning capabilities.
-
BrightInsight CEO Kal Patel M.D. discusses the future of regulated digital health for biopharma and medtech
In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.
-
Devices & Diagnostics, Health Tech
GE Healthcare closes $1.45B acquisition of BK Medical
The company would become part of GE’s ultrasound business, expanding its capabilities to include surgical visualization. GE plans to spin out its healthcare division into a publicly traded company in 2023.